Skip to content

Innoviva, Inc. INVA Total Current Assets

Total Current Assets at other companies

Pfizer logo
PfizerPFE
$42.82B-6.6%
Merck & Co. logo
Merck & Co.MRK
$35.02B-1.4%
AbbVie logo
AbbVieABBV
$33.53B+21.2%
Insmed logo
InsmedINSM
$1.61B+15.0%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$2.94B+21.4%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$348.7M+87.7%

Other financials

Income statement

See full
Revenue$98.0M+10.6%
Gross profit$75.8M+3.4%
Operating income$38.2M-7.9%
Net income$186.6M+501%
EPS (diluted)$2.22+400%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total debt$269.4M-40.3%
Total equity$1.3B
Total assets$1.8B+46.4%

Cash flow

See full
Operating cash flow$35.3M-27.4%
CapEx$492.0K
Free cash flow$34.8M-28.4%

Valuation

See full
Market cap$1.74B+51.8%
Enterprise value$1.4B+9.7%
P/E3.5×
P/S4.1×+1.0×

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s total current assets?
Innoviva, Inc. (INVA) reported total current assets of $772.62M in Q1 2026.
How has Innoviva, Inc.'s total current assets changed year-over-year?
Innoviva, Inc.'s total current assets increased by 32.7% year-over-year, from $582.02M to $772.62M.
What is the long-term trend for Innoviva, Inc.'s total current assets?
Over 5 years (2020 to 2025), Innoviva, Inc.'s total current assets has grown at a 16.3% compound annual growth rate (CAGR), from $342.06M to $727.52M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.